Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.
Heuser M, Heida B, Büttner K, Wienecke CP, Teich K, Funke C, Brandes M, Klement P, Liebich A, Wichmann M, Neziri B, Chaturvedi A, Kloos A, Mintzas K, Gaidzik VI, Paschka P, Bullinger L, Fiedler W, Heim A, Puppe W, Krauter J, Döhner K, Döhner H, Ganser A, Stadler M, Hambach L, Gabdoulline R, Thol F.
Heuser M, et al. Among authors: liebich a.
Blood Adv. 2021 May 11;5(9):2294-2304. doi: 10.1182/bloodadvances.2021004367.
Blood Adv. 2021.
PMID: 33929500
Free PMC article.